FLT3 Gene Mutation in Brazilian Children with B-ALL
Author Information
Author(s): Biojone Estefânia Rodrigues, Guido Bruna Cândido, Cavalcante Larissa Lemos Mendanha, dos Santos Júnior Agenor de Castro Moreira, de Pontes Robéria Mendonça, Furtado Felipe Magalhães, Córdoba José Carlos, Magalhães Isis Maria Quezado, de Oliveira Diêgo Madureira, Camargo Ricardo
Primary Institution: Children’s Hospital of Brasília, Brasília, Brazil
Hypothesis
What is the frequency and clinical impact of FLT3 mutations in pediatric patients with B-ALL?
Conclusion
FLT3 mutations were found in 5.1% of pediatric B-ALL patients, but they did not significantly impact relapse rates or survival.
Supporting Evidence
- FLT3 mutations were found in 5.1% of patients.
- Two patients with FLT3 mutations experienced disease relapse.
- FLT3 expression levels were higher in patients with mutations compared to wild-type patients.
Takeaway
This study looked at kids with a type of leukemia and found that a specific gene mutation happens in a small number of them, but it doesn't seem to change how well they do in treatment.
Methodology
The study evaluated 156 children with B-ALL using RFLP and fragment analysis for FLT3 mutations and qPCR for FLT3 expression.
Limitations
The small sample size and limited follow-up time restrict the interpretation of findings.
Participant Demographics
Patients aged 1–17 years, with a median age of 4 years and a sex ratio of 1.05 (80 males to 76 females).
Statistical Information
P-Value
0.08
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website